H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy
Tweet Send to a Friend
(Updated - June 23, 2026 6:48 AM EDT)
H.C. Wainwright analyst Matthew Keller initiates coverage on Seres Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Matthew Keller initiates coverage on Seres Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
